Vor Biopharma competitorsClear all

Vor Biopharma's top competitors include DNAtriX, Inhibitor Therapeutics, Dauntless Pharmaceuticals and Actuate Therapeutics.
Vor Biopharma
Vor Biopharma
Vor Biopharma is a biopharmaceutical company developing novel therapies with potential for treating cancer.
DNAtriX
DNAtriX
DNAtrix is a biotechnology company developing virus-driven immunotherapies for cancer.
Inhibitor Therapeutics
Inhibitor Therapeutics
Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biopharmaceutical company focused on the development of specialty drugs.
Actuate Therapeutics
Actuate Therapeutics
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases.
Founding Date
Founding Date
2016
Founding Date
2005
Founding Date
1992
Founding Date
2015
Founding Date
2015
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Houston, US HQ
San Diego, US
Locations
Tampa, US HQ
Locations
San Diego, US HQ
Locations
Fort Worth, US HQ
Dublin, IE
Employees
Employees
5
Employees
20
Employees
233% decrease
Employees
3
Employees
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
163
Twitter followers
75
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
384862
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
297747

Funding

Latest funding round
Latest funding round
$ 110m (4 months ago)
Latest funding round
$ 15.5m (about 2 years ago)
Latest funding round
N/A
Latest funding round
$ 25m (over 3 years ago)
Latest funding round
$ 6.5m (12 months ago)
Total funding raised
Total funding raised
$ 152m
Total funding raised
$ 54.2m
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
$ 31.2m
For sources of this data, please see the company profile

View company profiles

DNAtriX
HQ
Houston, US
Employees
20

DNAtrix is a biotechnology company developing virus-driven immunotherapies for cancer.

View company
Inhibitor Therapeutics
HQ
Tampa, US
Employees
2↓ 33% decrease

Inhibitor Therapeutics (formerly known as HedgePath Pharmaceuticals) is a pharmaceutical company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders.

View company
Dauntless Pharmaceuticals
HQ
San Diego, US
Employees
3

Dauntless Pharmaceuticals is a biopharmaceutical company focused on the development of specialty drugs.

View company
Actuate Therapeutics
HQ
Fort Worth, US

Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases.

View company